Variant report
Variant | esv3518504 |
---|---|
Chromosome Location | chr3:34720759-34728145 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:33924890..33925565-chr3:34725299..34726001,2 | MCF-7 | breast: | |
2 | chr3:34021801..34022436-chr3:34725109..34725617,2 | MCF-7 | breast: | |
3 | chr3:33925132..33926279-chr3:34725034..34726059,3 | K562 | blood: | |
4 | chr3:34301756..34302335-chr3:34725095..34725974,2 | K562 | blood: | |
5 | chr3:34661198..34662050-chr3:34724950..34725978,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556781788 | chr3:34720796-34720797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141394248 | chr3:34720817-34720818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542457156 | chr3:34720830-34720831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74209330 | chr3:34720848-34720849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368209482 | chr3:34720850-34720851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs398062231 | chr3:34720851-34720852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112696922 | chr3:34720861-34720862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547951378 | chr3:34720862-34720863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114469784 | chr3:34720872-34720873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528400085 | chr3:34720875-34720876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541013879 | chr3:34720916-34720917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192504072 | chr3:34720924-34720925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369072640 | chr3:34720936-34720937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185487297 | chr3:34720946-34720947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13060690 | chr3:34720949-34720950 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs531124951 | chr3:34720957-34720958 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570515812 | chr3:34720962-34720963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549625659 | chr3:34721002-34721003 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76001532 | chr3:34721062-34721063 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535300391 | chr3:34721063-34721064 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190413916 | chr3:34721066-34721067 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571173481 | chr3:34721069-34721070 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs28505771 | chr3:34721071-34721072 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs569525453 | chr3:34721118-34721119 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6799184 | chr3:34721126-34721127 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs181668786 | chr3:34721138-34721139 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542393839 | chr3:34721154-34721155 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554380189 | chr3:34721166-34721167 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6799362 | chr3:34721181-34721182 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs540493924 | chr3:34721186-34721187 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74590964 | chr3:34721194-34721195 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6799370 | chr3:34721197-34721198 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs143924761 | chr3:34721215-34721216 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533614721 | chr3:34721217-34721218 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563749957 | chr3:34721222-34721223 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563792743 | chr3:34721258-34721259 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146833579 | chr3:34721285-34721286 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2160469 | chr3:34721333-34721334 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs148983825 | chr3:34721348-34721349 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547229275 | chr3:34721366-34721367 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571884938 | chr3:34721382-34721383 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184421106 | chr3:34721388-34721389 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2160468 | chr3:34721392-34721393 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs568597950 | chr3:34721408-34721409 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143787149 | chr3:34721416-34721417 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554267738 | chr3:34721417-34721418 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572656498 | chr3:34721434-34721435 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533758622 | chr3:34721458-34721459 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189054216 | chr3:34721480-34721481 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181148146 | chr3:34721501-34721502 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Wilms tumour | 17204608 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21364760 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:34717800-34721600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr3:34718200-34721000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:34718400-34721600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr3:34719800-34721400 | Enhancers | Fetal Intestine Large | intestine |
5 | chr3:34719800-34722600 | Enhancers | K562 | blood |
6 | chr3:34720200-34720800 | Enhancers | Fetal Heart | heart |
7 | chr3:34720400-34721000 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr3:34721000-34721600 | ZNF genes & repeats | Fetal Intestine Small | intestine |
9 | chr3:34721000-34721800 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
10 | chr3:34721000-34721800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr3:34721200-34721600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr3:34721200-34721600 | ZNF genes & repeats | Thymus | Thymus |
13 | chr3:34721600-34721800 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr3:34721600-34722200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr3:34722200-34734400 | Weak transcription | Thymus | Thymus |
16 | chr3:34725200-34725400 | Enhancers | Fetal Intestine Large | intestine |
17 | chr3:34725200-34725800 | Enhancers | Primary monocytes fromperipheralblood | blood |
18 | chr3:34725200-34725800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
19 | chr3:34725400-34729000 | Weak transcription | Fetal Intestine Large | intestine |
20 | chr3:34727000-34727200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |